Twist Bioscience Corporation
NASDAQ:TWST
45.52 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -204.618 | -217.863 | -152.098 | -139.931 | -107.669 | -71.236 | -59.31 | -44.088 |
| Depreciation & Amortization
| 29.31 | 16.514 | 9.75 | 6.677 | 6.111 | 5.727 | 5.021 | 4.229 |
| Deferred Income Tax
| -0.41 | 0 | 0.63 | -0.214 | -1.06 | 0.042 | 0.768 | -0.068 |
| Stock Based Compensation
| 30.278 | 79.664 | 36.998 | 17.096 | 11.17 | 2.961 | 1.891 | 0.857 |
| Change In Working Capital
| -1.009 | -5.356 | -9.381 | -25.176 | 2.996 | -4.22 | -0.129 | 0.24 |
| Accounts Receivables
| -4.32 | -9.622 | -2.202 | -14.272 | -6.685 | -3.073 | -1.623 | -0.702 |
| Inventory
| 7.238 | -7.536 | -19.489 | -4.956 | -1.302 | -4.202 | -0.599 | -1.228 |
| Accounts Payables
| -2.508 | 7.383 | 8.542 | -5.506 | 3.278 | 3.759 | 0.56 | 0.466 |
| Other Working Capital
| -0.41 | 4.419 | 3.768 | -0.442 | 7.705 | -0.704 | 1.533 | 1.704 |
| Other Non Cash Items
| 3.975 | 2.656 | 1.857 | -0.707 | 0.515 | 0.562 | 0.458 | 0.238 |
| Operating Cash Flow
| -142.474 | -124.385 | -112.244 | -142.255 | -87.937 | -66.164 | -51.301 | -38.592 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -27.779 | -101.857 | -27.061 | -9.868 | -14.757 | -3.688 | -6.594 | -6.229 |
| Acquisitions Net
| 5.86 | -8.16 | -0.483 | 104.782 | 0.021 | 0.017 | 0.266 | 0.254 |
| Purchases Of Investments
| -76.345 | -217.639 | -58.795 | -202.882 | -177.574 | -3.523 | -40.587 | -27.29 |
| Sales Maturities Of Investments
| 154.736 | 100.481 | 242.494 | 98.1 | 87.5 | 34.5 | 36.925 | 0 |
| Other Investing Activites
| -5.86 | -5.755 | 183.699 | -104.782 | -90.053 | -0.434 | 0.12 | 0.174 |
| Investing Cash Flow
| 50.612 | -232.93 | 156.155 | -114.65 | -104.81 | 26.872 | -9.87 | -33.345 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | -1.558 | -3.333 | -3.333 | -2.5 | 0 | -4.173 | -0.426 |
| Common Stock Issued
| 5.316 | 269.822 | 343.364 | 309.486 | 156.208 | 0.331 | 0.205 | 0.152 |
| Common Stock Repurchased
| -4.405 | -7.754 | -10.849 | -2.421 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.316 | 10.024 | 343.364 | 309.486 | 4.87 | 88.491 | 67.77 | 69.922 |
| Financing Cash Flow
| 0.911 | 270.534 | 329.182 | 303.732 | 158.578 | 88.822 | 63.802 | 69.648 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.027 | -0.319 | 0.02 | 0.021 | 0.03 | 0 | 0 | 0 |
| Net Change In Cash
| -90.978 | -87.1 | 373.113 | 46.848 | -34.139 | 49.53 | 2.631 | -2.289 |
| Cash At End Of Period
| 289.281 | 380.259 | 467.359 | 94.246 | 47.398 | 80.757 | 31.227 | 28.596 |